FDA.reportPublic FDA data

Neupro 8 MG/Day 24HR Transdermal System

RxCUI
1251922
RxNorm name
Neupro 8 MG/Day 24HR Transdermal System
Display name
Neupro 8 MG/Day 24HR Transdermal System
Full name
Neupro 8 MG/Day 24HR Transdermal System
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:08

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
NeuproROTIGOTINEUCB, Inc.939e28c5-f3a9-42c0-9a2d-8d471d82a6e02025-06-24Warnings, Adverse reactionsExact identifier
rxcui: 1251922

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
939e28c5-f3a9-42c0-9a2d-8d471d82a6e0Neupro 8 MG/Day 24HR Transdermal System [PSN] · 24 HR rotigotine 0.333 MG/HR Transdermal System [Neupro] [SBD] · 24 HR Neupro 0.333 MG/HR Transdermal System [SY] · Neupro 8 MG/Day 24 HR Transdermal Patch [SY] · Neupro 8 MG/Day 24HR Transdermal System [SY]520These highlights do not include all the information needed to use NEUPRO safely and effectively. See full prescribing information for NEUPRO. NEUPRO (rotigotine transdermal system) Initial U.S. Approval: 200720250624